Literature DB >> 10551282

Beta4-adrenoceptors are more effective than beta1-adrenoceptors in mediating arrhythmic Ca2+ transients in mouse ventricular myocytes.

N S Freestone1, J F Heubach, E Wettwer, U Ravens, D Brown, A J Kaumann.   

Abstract

Putative beta4-adrenoceptors mediate cardiostimulation and arrhythmias in mammalian heart. Both beta1- and putative beta4-adrenoceptors mediate arrhythmias but through different mechanisms. To elucidate further the mechanisms of cardiostimulation and arrhythmias we measured Ca2+ transients and L-type Ca2+ currents in mouse ventricular myocytes. We used (-)-CGP 12177, an antagonist of beta1- and beta2-adrenoceptors with agonist properties at the putative beta4-adrenoceptor, and (-)-isoprenaline as an agonist for beta1- and beta2-adrenoceptors. (-)-CGP 12177 increased Ca2+ transients in electrically stimulated cells loaded with Indo-1. The maximum increase of Ca2+ transients caused by (-)-CGP 12177 amounted to approximately one-third of that caused by maximally effective (-)-isoprenaline concentrations. Both (-)-CGP 12177 and (-)-isoprenaline caused concentration-dependent arrhythmic Ca2+ transients. The arrhythmias appeared at paced Ca2+ transients and between paced Ca2+ transients. The arrhythmic potency of (-)-CGP 12177 (-logEC50=9.4) was approximately 40 times greater than that of (-)-isoprenaline (-logEC50=7.8). L-type Ca2+ current was measured in the whole cell configuration of the patch clamp technique. In the presence of both 3-isobutyl 1-methylxanthine (6 micromol/l) and (-)-propranolol (500 nmol/l), (-)-CGP 12177 (100 nmol/l) increased significantly L-type Ca2+ current by 19% of the effect of (-)-isoprenaline. The (-)-CGP 12177-evoked increase of Ca2+ transients contrasts with the smaller effects on L-type Ca2+ current, suggesting that activation of the putative beta4-adrenoceptor causes a more efficient Ca2+-induced Ca2+ release than activation of the beta1-adrenoceptor. Beta4-Adrenoceptors mediate arrhythmias with smaller Ca2+ transients and smaller increases of L-type Ca2+ current than beta1-adrenoceptors, in line with different but still unknown mechanisms as previously suggested for the intact heart.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551282     DOI: 10.1007/s002109900075

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.

Authors:  D Sarsero; P Molenaar; A J Kaumann; N S Freestone
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Human atrial β(1L)-adrenoceptor but not β₃-adrenoceptor activation increases force and Ca(2+) current at physiological temperature.

Authors:  Torsten Christ; Peter Molenaar; Paul M Klenowski; Ursula Ravens; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Positive inotropic and lusitropic effects mediated via the low-affinity state of beta1-adrenoceptors in pithed rats.

Authors:  Agnieszka Zakrzeska; Eberhard Schlicker; Grzegorz Kwolek; Hanna Kozłowska; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

4.  Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium.

Authors:  Martin D Lowe; James A Lynham; Andrew A Grace; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  MH-3: evidence for non-competitive antagonism towards the low-affinity site of β1-adrenoceptors.

Authors:  Eberhard Schlicker; Anna Pędzińska-Betiuk; Hanna Kozłowska; Natalia Szkaradek; Dorota Żelaszczyk; Marta Baranowska-Kuczko; Katarzyna Kieć-Kononowicz; Henryk Marona; Barbara Malinowska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-05-03       Impact factor: 3.000

6.  Contribution of beta-adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wildtype and beta(3)-adrenoceptor knockout mice.

Authors:  J Oostendorp; F Preitner; J Moffatt; M Jimenez; J P Giacobino; P Molenaar; A J Kaumann
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

7.  Overexpression of beta 1-adrenoceptors in adult rat ventricular myocytes enhances CGP 12177A cardiostimulation: implications for 'putative' beta 4-adrenoceptor pharmacology.

Authors:  Clive J Lewis; Haibin Gong; Morris J Brown; Sian E Harding
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

8.  Atypical cardiostimulant beta-adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues.

Authors:  Barbara Malinowska; Katarzyna Kieć-Kononowicz; Karsten Flau; Grzegorz Godlewski; Hanna Kozłowska; Markus Kathmann; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

9.  Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling.

Authors:  Helen Kiriazis; Niquita Tugiono; Qi Xu; Xiao-Ming Gao; Nicole L Jennings; Ziqui Ming; Yidan Su; Paul Klenowski; Roger J Summers; Alberto Kaumann; Peter Molenaar; Xiao-Jun Du
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

10.  Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling and arrhythmias in the heart evoked by β-adrenergic stimulation.

Authors:  Merle Nebel; Alexander P Schwoerer; Dominik Warszta; Cornelia C Siebrands; Ann-Christin Limbrock; Joanna M Swarbrick; Ralf Fliegert; Karin Weber; Sören Bruhn; Martin Hohenegger; Anne Geisler; Lena Herich; Susan Schlegel; Lucie Carrier; Thomas Eschenhagen; Barry V L Potter; Heimo Ehmke; Andreas H Guse
Journal:  J Biol Chem       Date:  2013-04-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.